Glycaemic goal attainment and hypoglycaemia outcomes in type 2 diabetes patients initiating insulin glargine 300 units/mL or 100 units/mL: Real-world results from the DELIVER Naïve cohort study.

Timothy S BaileyFang Liz ZhouRishab A GuptaRonald PreblickVineet E GuptaPaulos BerhanuLawrence Blonde

Published in: Diabetes, obesity & metabolism (2019)

Among insulin-naïve adults with T2D, Gla-300 was associated with significantly better HbA1c reductions (latest value during 90-180-day follow-up) and similar or improved hypoglycaemia outcomes (3- and 6-month follow-up) than Gla-100.

Keyphrases

type diabetes
glycemic control
end stage renal disease
chronic kidney disease
cardiovascular disease
ejection fraction
insulin resistance
newly diagnosed
peritoneal dialysis
patient reported outcomes
adipose tissue